Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
The Oncologist|January 6, 2005
How rapidly do oncologists respond to clinical trial data?Aman Buzdar, Cynthia MacahiligClinical Breast Cancer|May 21, 2003
Anastrozole as adjuvant therapy for early-stage breast cancer: implications of the ATAC trialAman BuzdarThe Journal of Steroid Biochemistry and Molecular Biology|April 30, 2005
Are aromatase inhibitors superior to antiestrogens?Anthony Howell, Aman BuzdarThe Surgical Clinics of North America|July 24, 2003
The current status of aromatase inhibitors in the management of breast cancerMichael Baum, Aman BuzdarSeminars in Oncology|July 26, 2002
Recent advances in aromatase inhibitor therapy for breast cancerVasily J Assikis, Aman BuzdarClinical Therapeutics|December 25, 2003
Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancerW Robert Simons, David Jones, Aman BuzdarJournal of the American Pharmacists Association : Japha|March 18, 2014
Mealtime-related dosing directions for proton-pump inhibitors in gastroesophageal reflux disease: physician knowledge, patient adherenceCaitlyn Solem, Reema Mody, Jennifer Stephens, et al.Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|March 1, 2013
Parenteral nutrition prescribing pattern: a medical chart review of 191 preterm infantsRobin S Turpin, Frank Xiaoqing Liu, Matt Prinz, et al.The Journal of Pain|July 15, 2009
Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxelCielito C Reyes-Gibby, Phuong Khang Morrow, Aman Buzdar, et al.Journal of Comparative Effectiveness Research|March 6, 2019
Treatment patterns and outcomes for patients with unresectable stage III and metastatic melanoma in the USAAhmad Tarhini, Christopher Atzinger, Komal Gupte-Singh, et al.Pageof 6